Sulfaphenazole NEW
| Price | $50 |
| Package | 100mg |
| Supply Ability: | 10g |
| Update Time: | 2026-06-12 |
Product Details
| Product Name: Sulfaphenazole | CAS No.: 526-08-9 |
| Purity: 99.97% | Supply Ability: 10g |
| Release date: 2026/06/12 |
Product Introduction
Bioactivity
| Name | Sulfaphenazole |
| Description | Sulfaphenazole (Plisulfan) is an inhibitor of CYP2C9 (Ki: 0.3 μM) that demonstrates at least 100-fold selectivity over other CYP450 isoforms (Ki: 63/29 μM for CYP2C8/CYP2C18, respectively, and no activity at CYP1A1, CYP1A2, CYP3A4, CYP2C19). At 10 μM, sulfaphenazole has been shown to inhibit endothelium-derived hyperpolarizing factor synthase, a CYP450 isozyme in the porcine coronary artery homologous to CYP2C8/9 that generates reactive oxygen species in coronary endothelial cells and modulates vascular tone and homeostasis. |
| Storage | Store at low temperature Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 10 mg/mL (31.81 mM), Solution. 10% DMSO+90% Saline : < 10 mg/mL (31.81 mM), Lower concentrations may be soluble, but exact solubility limit is unknown. Ethanol : 0.5 mg/mL (1.59 mM), Sonication is recommended. DMSO : 250 mg/mL (795.27 mM), Sonication is recommended. |
| Keywords | Sulfaphenazole | Inhibitor | inhibit | CYP2C9 | Bacterial |
| Inhibitors Related | Neomycin sulfate | Aceglutamide | Levulinic acid | D(+)-Raffinose pentahydrate | Sulfamethoxazole sodium | Terbinafine hydrochloride | Doxycycline | Formamide | Hyaluronic acid sodium (MW 20 kDa) | Sodium diacetate | Sodium bicarbonate | Alginic acid |
| Related Compound Libraries | Highly Selective Inhibitor Library | Bioactive Compound Library | Drug Repurposing Compound Library | Inhibitor Library | Anti-Cancer Approved Drug Library | FDA-Approved Drug Library | Anti-Aging Compound Library | Immunology/Inflammation Compound Library | Bioactive Compounds Library Max | Anti-Infection Compound Library | Human Metabolite Library | Anti-Cancer Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $884.00 |
VIP7Y
|
Shaanxi Dideu Medichem Co. Ltd
|
2025-12-24 | |
| $1.10 |
VIP6Y
|
Dideu Industries Group Limited
|
2025-11-18 | |
| $5.50 |
VIP7Y
|
Career Henan Chemical Co
|
2020-01-13 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY